RWA
GNMK

Ropes Wealth Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Ropes Wealth Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-633
Closed -$3K – 788
2017
Q4 		$3K Hold
633
– – ﹤0.01% 702
2017
Q3 		$6K Buy
+633
New +$6.58K ﹤0.01% 585

Other funds holding GNMK

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ropes Wealth Advisors's GNMK Position: Q1 2018 in Review

Ropes Wealth Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2018, closing a stake of 633 shares — an estimated $3K sold.

Ropes Wealth Advisors first reported a position in GNMK in Q3 2017 and held it in 2 quarters. The position peaked at $6K in Q3 2017. 98 funds tracked by Wall St. Rank hold GNMK as of Q1 2018.

  • Ropes Wealth Advisors reported no remaining GenMark Diagnostics, Inc position as of Q1 2018 after selling out during the quarter.
  • Ropes Wealth Advisors sold 633 GenMark Diagnostics, Inc shares in Q1 2018, an estimated $3K.
  • Ropes Wealth Advisors first reported a position in GenMark Diagnostics, Inc in Q3 2017 and held it in 2 quarters.
  • Ropes Wealth Advisors's GenMark Diagnostics, Inc position peaked at $6K in Q3 2017.
  • 98 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2018.

Based on Ropes Wealth Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.